Geoff Benic, CEO of Altrova Health Inc., will present at the Life Sciences Investor Forum on September 17th at 2:30 PM ET. The forum, hosted by VirtualInvestorConferences.com, allows real-time interaction with investors and industry professionals. Recently, Altrova signed a two-year exclusive distribution agreement in the U.S. with Reliability Funding LLC for certain products, along with raising up to US$500,000 through a private placement to support the launch. The company also reported its first commercial revenue of $112,000 for nine months ending June 30, 2026, an increase from $15,551 in the previous period.
Written by the local model on 2026-09-16,
using this article's own text rather than the other coverage of the
same event (that is the story summary below).
Story summary
Altrova Health Inc., a Canadian company focused on health, safety, and rapid response technologies, announced that Geoff Benic, the Chief Executive Officer, will present at the Life Sciences Investor Forum hosted by VirtualInvestorConferences.com on September 17th, 2026, starting at 2:30 PM ET. The event is a live, interactive online forum where investors and industry professionals can submit questions to Altrova Health management in real time. A replay of the presentation will be available afterward for those unable to attend the live session.
Written for “Altrova Health Presentation” on 2026-09-17,
grounded in this article and the 0 other(s) covering the same event.
Why this leaning score
This article does not take a side on a contested political
question, so it has no leaning score. That is an
answer rather than a gap: a match report or a rescue can be warmly
or critically written without being left or right, and scoring it
anyway is how approval of a subject gets recorded as a political
position.
No political leaning scored for article 10830 · logged 2026-09-16
Altrova Health Inc. (CSE: ROVA) (OTCQB: ATVHF) (FSE: WF8) (“Altrova Health” or the “Company”), based in Canada, focused on health, safety, and rapid response technologies, today announced that Geoff Benic, Chief Executive Officer, will present live at the Life Sciences Investor Forum hosted by VirtualInvestorConferences.com on September 17th, 2026
DATE: September 17th
TIME: 2:30 PM ET
The event will be conducted as a live, interactive online forum, offering investors and industry professionals within the life sciences community the opportunity to submit questions to management in real time.
asserted
event → base → time
A replay of the webcast will be available following the conclusion of the conference.
asserted
replay → follow → conference
It is recommended that online investors pre-register and run the online system check to expedite participation and receive event updates.
asserted
investors → recommend → updates
Recent Company Highlights
- Exclusive U.S. Distribution Agreement – The Company entered into an exclusive distribution agreement with Reliability Funding LLC (“Reliability”), appointing Reliability as its exclusive sales agent and distributor for the Company’s detection, protection and wellness product portfolio across the United States (excluding the NIRLAB SA (“NIRLAB”) NIRLIGHT device).
asserted
Company → enter → device
The agreement has an initial two-year term with renewal tied to agreed performance thresholds, and Reliability is compensated through a share of profit on U.S. sales.
asserted
Reliability → have → sales
Concurrently, the Company announced a non-brokered private placement for gross proceeds of up to US$500,000 to fund inventory, customer onboarding and sales support for the U.S. launch.
asserted
Company → announce → launch
- First Commercial Revenue in Company History – For the nine months ended June 30, 2026, the Company reported revenue of $112,000, up from $15,551 in the prior comparative period,
asserted
Company → end → period
as distribution and commercialization initiatives began converting into recurring commercial activity.
asserted
initiatives → begin → activity
General and administrative, investor relations and professional fees each declined year-over-year even as commercial operations scaled.
asserted
operations → decline → year
- Board Leadership Transition – The Board appointed The Hon. Tony Clement as Chairman of the Board of Directors of Altrova Health.
asserted
Board → appoint → Health
The Company also continued to expand its distribution network through NIRLAB device sales, partnerships with Indigenous and First Nations communities, and a planned relaunch of the Drug Lab 118 Ltd. rapid detection strip portfolio.
asserted
Company → continue → portfolio
Altrova Health Inc. (CSE: ROVA) (OTCQB: ATVHF) (FSE: WF8) is a Canadian public company building a growing portfolio of health solutions across detection, protection, treatment, and wellness.
asserted
Inc. → build → detection
The Company’s current product portfolio includes exclusive Canadian distribution rights for the NIRLAB SA (“NIRLAB”) NIRLIGHT drug analysis device, the O-Spray product line, and the rapid detection strip portfolio of its subsidiary Drug Lab 118 Ltd.
asserted
portfolio → include → Ltd.
About Virtual Investor Conferences®
Virtual Investor Conferences (VIC) is the leading proprietary investor conference series that provides an interactive forum for publicly traded companies to seamlessly present directly to investors.
asserted
companies → lead → investors
Providing a real-time investor engagement solution, VIC is specifically designed to offer companies more efficient investor access.
asserted
VIC → provide → access
Replicating the components of an on-site investor conference, VIC offers companies enhanced capabilities to connect with investors, schedule targeted one-on-one meetings and enhance their presentations with dynamic video content.
asserted
VIC → replicate → content
Accelerating the next level of investor engagement, Virtual Investor Conferences delivers leading investor communications to a global network of retail and institutional investors.
asserted
Conferences → accelerate → investors
The Aporia
